Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fever

Why Tweaking Molecular Structures Can Be Hazardous to Our Health

Simon M. Helfgott, MD  |  June 1, 2014

The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development

Filed under:Biologics/DMARDsDrug UpdatesOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:anti-inflammatoryBiosimilarsdrugHelfgottpatient careResearchrheumatologistrofecoxib

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS  |  May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

Filed under:ConditionsVasculitis Tagged with:drugGiant Cell ArteritisGlucocorticoidsimaginginfliximablarge-vessel vasculitisMethotrexatePainpatient careprednisonerheumatologistrituximabTakayasu’s ArteritistocilizumabTreatmentVasculitis

Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

Filed under:ConditionsDrug UpdatesGout and Crystalline ArthritisMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatoryCardiovascular diseaseColchicinecrystal arthritisGoutimagingOsteoarthritispatient carerheumatology symposium

Exploring Kawasaki Disease

Mary Beth Son, MD  |  April 2, 2014

New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:ACR/ARHP Annual Meetingimmune intravenous globulininfliximabJuvenile idiopathic arthritisKawasaki diseasepatient carerheumatologist

Evolutionary Medicine Provides Insight into the Chronic Inflammatory State Note Rheumatologists at the 2013 ACR/ARHP Annual Meeting

Mary Beth Nierengarten  |  March 1, 2014

Studies on metabolism, neuroendocrinology, and immunology can broaden understanding of the pathophysiology of chronic inflammatory diseases

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)ImmunologyInflammatory DiseasemetabolismResearchrheumatology

2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease

Mary Beth Nierengarten  |  February 1, 2014

New data examine infliximab as a treatment option, and updated diagnostic criteria aids physicians in recognizing KD and detecting cardiac involvement in patients

Filed under:Career DevelopmentEducation & TrainingMeeting ReportsProfessional TopicsResearch Rheum Tagged with:ACR/ARHP Annual MeetingCardiacDiagnosisdrugimaginginfliximabKawasaki diseasepatient carePediatricsResearchrheumatologistTreatment

Parents Give Back after Watching Daughter’s Struggle with Systemic Juvenile Idiopathic Arthritis

Staff  |  February 1, 2014

Diagnosis prompts Steve and Debbie Russell to support the Rheumatology Research Foundation

Filed under:ConditionsFrom the CollegeLegislation & AdvocacyProfessional TopicsProfilesResearch RheumRheumatoid Arthritis Tagged with:AdvocacydonationsFundingProfileResearchRheumatoid arthritisrheumatologistRheumatology Research Foundationsystemic juvenile idiopathic arthritis

Inflammatory Myopathies Difficult to Diagnose, Treat

Jonathan Jones, MD, and Robert Wortmann, MD  |  December 1, 2013

Without a single set of diagnostic criteria for identifying polymyositis, dermatomyositis, or myositis and scant evidence-based therapeutic guidelines, these rare muscle diseases can be hard to manage

Filed under:ConditionsMyositisOther Rheumatic Conditions Tagged with:dermatomyositisDiagnosisinflammatory myopathymyositispolymyositisrheumatologyTreatment

Rheuminations: Rheumatologists Seek Better Understanding of Fibrosing Disorders

Simon M. Helfgott, MD  |  December 1, 2013

Research into scleroderma, fibrosis, and Raynaud’s phenomenon may provide clues into the pathogenesis of systemic sclerosis

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:fibrosisPathogenesisRaynaud’s phenomenonSclerodermaSystemic sclerosis

Ethics Forum: Difficult Parents and Termination of Care in Pediatrics

Lawrence K. Jung, MD  |  November 1, 2013

A pediatric rheumatologist faces continuity of care issues for a patient with systemic juvenile idiopathic arthritis whose parents are disruptive to the medical practice

Filed under:ConditionsEthicsPediatric ConditionsPractice SupportProfessional Topics Tagged with:patient carePediatricrheumatologytermination

  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 54
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences